Published in J Cardiovasc Dis Res on October 01, 2012
Comparison of mobile apps for the leading causes of death among different income zones: a review of the literature and app stores. JMIR Mhealth Uhealth (2014) 1.00
Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels (2014) 0.79
Microextraction by Packed Sorbent (MEPS) and Solid-Phase Microextraction (SPME) as Sample Preparation Procedures for the Metabolomic Profiling of Urine. Metabolites (2014) 0.78
Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases. Int J Clin Exp Med (2015) 0.76
Reply to the letter "Mean platelet volume as a surrogate marker of inflammation in systemic lupus erythematosus". Clin Rheumatol (2014) 0.75
Detection of Cardiovascular Disease Risk's Level for Adults Using Naive Bayes Classifier. Healthc Inform Res (2016) 0.75
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ (2002) 7.14
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol (2002) 2.88
Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation (1994) 2.68
Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol (2006) 2.19
Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.71
Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost (2008) 1.69
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int (1989) 1.65
Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res (2010) 1.60
Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol (1995) 1.51
Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study. Am J Med Sci (1989) 1.44
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant (1998) 1.42
Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis (2004) 1.30
Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med (2002) 1.24
Microalbuminuria and cardiovascular risk. Am J Hypertens (2004) 1.14
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial. Diabetes Care (2003) 1.02
Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res (2012) 0.96
Atherosclerosis in coronary artery and aorta in a semi-urban population by applying modified American Heart Association classification of atherosclerosis: An autopsy study. J Cardiovasc Dis Res (2012) 0.90
Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions. Can J Cardiol (2009) 0.88
Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study. Stroke (2010) 0.86
QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria. J Cardiovasc Dis Res (2012) 0.83
Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease? J Cardiovasc Dis Res (2012) 0.83
Apoptosis of endothelial progenitor cells in a metabolic syndrome experimental model. J Cardiovasc Dis Res (2012) 0.81
Rhabdomyolysis caused by an unusual interaction between azithromycin and simvastatin. J Cardiovasc Dis Res (2012) 0.79
Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography. J Cardiovasc Dis Res (2012) 0.79
Vascular purpura revealing a severe dilated cardiomyopathy with left ventricular apical thrombus. J Cardiovasc Dis Res (2012) 0.78
Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate. Med Hypotheses (1996) 0.78
A patient of Ebstein's anomaly associated with biventricular noncompaction presented with Wolf Parkinson White syndrome - A rare presentation. J Cardiovasc Dis Res (2012) 0.77
Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients. J Cardiovasc Dis Res (2012) 0.77
Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology (2007) 1.65
Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology (2010) 1.17
Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. J Dig Dis (2012) 1.14
Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol (2008) 1.00
Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology (2011) 0.98
The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger. Cardiovasc Toxicol (2007) 0.94
Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol (2008) 0.93
Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress. Exp Biol Med (Maywood) (2008) 0.93
Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster. J Nutr (2011) 0.84
Rapid differentiation of in vitro cellular responses to toxic chemicals by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Environ Toxicol Chem (2014) 0.79
Cruciferous dithiolethione-mediated coordinated induction of total cellular and mitochondrial antioxidants and phase 2 enzymes in human primary cardiomyocytes: cytoprotection against oxidative/electrophilic stress and doxorubicin toxicity. Exp Biol Med (Maywood) (2009) 0.77
Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method. Sleep Breath (2012) 0.77
Protection against peroxynitrite-induced DNA damage by mesalamine: implications for anti-inflammation and anti-cancer activity. Mol Cell Biochem (2013) 0.77
Ethyl pyruvate inhibits peroxynitrite-induced DNA damage and hydroxyl radical generation: implications for neuroprotection. Neurochem Res (2009) 0.77
Inhibition of peroxynitrite-mediated DNA strand cleavage and hydroxyl radical formation by aspirin at pharmacologically relevant concentrations: implications for cancer intervention. Biochem Biophys Res Commun (2009) 0.75
EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin. Mol Cell Biochem (2011) 0.75
Preface to the Journal of Cardiovascular Disease Research, third issue 2012. J Cardiovasc Dis Res (2012) 0.75
Induction of oxidative DNA damage by mesalamine in the presence of copper: a potential mechanism for mesalamine anticancer activity. Toxicology (2010) 0.75
Preface JCDR 2013 issue 2. J Cardiovasc Dis Res (2013) 0.75